Newsletters

Mg2+ Influx Mediated by TRPM7 Triggers the Initiation of Muscle Stem Cell Activation

[Science Advances] Scientists identified transient receptor potential melastatin 7 (TRPM7), an Mg2+-permeable ion channel, as a critical regulator of muscle stem cell activation.

CAR T-Cell Therapy Response Varies by Extranodal Disease Site in Large B-Cell Lymphoma

[Blood Cancer Journal] Investigators retrospectively analyzed 283 adults treated with commercial CD19 CAR-T therapy, assessing 958 PET-CT scans across four time points: pre-apheresis, pre-lymphodepletion, best response, and relapse.

Hippocampal Output Suppresses Orbitofrontal Cortex Schema Cell Formation

[Nature Neuroscience] Researchers tested between a serial model and a parallel model by asking how schema correlated in rat orbitofrontal cortex would be affected by inactivating the output of the hippocampus, after learning and during transfer across problems.

ELANE Enhances KEAP1 Protein Stability and Reduces NRF2-Mediated Ferroptosis Inhibition in Metabolic Dysfunction-Associated Fatty Liver Disease

[Cell Death & Disease] Scientists used mice of Elane-knockout and wild-type, and their primary mouse hepatocytes to establish metabolic-associated fatty liver disease (MAFLD) models in vivo and in vitro for elucidating the role of Elane in ferroptosis of hepatocytes and MAFLD development.

Mg2+ Influx Mediated by TRPM7 Triggers the Initiation of Muscle Stem Cell Activation

[Science Advances] Scientists identified transient receptor potential melastatin 7 (TRPM7), an Mg2+-permeable ion channel, as a critical regulator of muscle stem cell activation.

Biocon Biologics Announces US FDA Approval for Jobevneâ„¢, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio

[Biocon Biologics] Biocon Biologics announced that the US FDA has approved Jobevneâ„¢, a biosimilar Bevacizumab for intravenous use. JOBEVNE is a VEGF inhibitor that binds with VEGF and blocks the interaction with its receptors to prevent angiogenesis.

NexThera Completes First Patient Enrollment in US Clinical Trial for ‘NT-101,’ an Eye Drop Treatment for Wet AMD

[NexThera Co., Ltd. (BioSpace)] NexThera Co., Ltd. announced that it has completed the first patient enrollment for its Phase I/IIa clinical trial of NT-101, a novel eye drop treatment for wet AMD, at a clinical trial site in Pennsylvania.

ICAM-1/CD18-Mediated Sequestration of Parasitized Phagocytes in Cortical Capillaries Promotes Neuronal Colonization by Toxoplasma gondii

[Nature Communications] Scientists investigated the mechanisms of blood-brain barrier traversal by T. gondii and T. gondii-infected leukocytes, using intracarotid arterial delivery into the cerebral circulation of mice.

Single-Cell and Spatial Transcriptomics Reveals the Key Role of MCAM+ Tip-Like Endothelial Cells in Osteosarcoma Metastasis

[NPJ Precision Oncology] Researchers constructed a single-cell atlas of endothelial cells (ECs) using single-cell transcriptomic data. It was found that tip-like ECs were abundant in the primary tumors and metastatic foci.

FLT1-Enriched Extracellular Vesicles Induce a Positive Feedback Loop between Nasopharyngeal Carcinoma Cells and Endothelial Cells to Promote Angiogenesis and Tumor Metastasis

[Oncogene] Investigators revealed that FLT1-enriched extracellular vesicles induced a positive feedback loop between nasopharyngeal carcinoma cells and endothelial cells to promote tumor angiogenesis and tumor metastasis.

Galectin-3: A Novel Biomarker of Glycogen Storage Disease Type III

[Cell Death Discovery] Researchers conducted a comparative gene expression analysis of several in vitro and in vivo models and identified galectin-3 as a potential biomarker of the disease.

Academy of Medical Sciences Awards Grants to King’S Researchers

[King's College London] Dr Robert Seaborne and Dr Simon Cleary have been awarded grants from The Academy of Medical Sciences through the Springboard scheme, which supports outstanding biomedical research.
spot_img